BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2176247)

  • 1. [The follow-up of trophoblastic disease by using an hCG-CTP enzyme immunoassay].
    Matsuura Y; Kashimura M; Shinohara M; Baba S; Kondo M; Kashimura Y
    Gan No Rinsho; 1990 Dec; 36(15):2559-62. PubMed ID: 2176247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Newly developed enzyme immunoassay for hCG-beta CTP and its significance in follow-up practice of trophoblastic disease].
    Sato Y; Sudo Y; Hirohashi T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1079-86. PubMed ID: 2427625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T; Mochizuki M; Nishimura R
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of human chorionic gonadotropin and alpha-subunit measurements.
    Hussa RO
    Obstet Gynecol; 1982 Jul; 60(1):1-12. PubMed ID: 6283446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
    Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of HCG and hCG beta determinations.
    Mann K; Saller B; Hoermann R
    Scand J Clin Lab Invest Suppl; 1993; 216():97-104. PubMed ID: 7690985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an immunoradiometric assay and a radioimmunoassay for the detection of free beta-human chorionic gonadotropin.
    Shapiro AI; Wu TF; Ballon SC; Lamb EJ
    Obstet Gynecol; 1985 Apr; 65(4):545-9. PubMed ID: 2580254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fragments of human chorionic gonadotropin (hCG): diagnosis of pregnancy and tumors].
    Lechner O; Dirnhofer S; Gerth R; Merz WE; Wick G; Berger P
    Wien Klin Wochenschr; 1995; 107(1):15-9. PubMed ID: 7871785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of beta-subunit chorionic gonadotropin as an aid in diagnosis of trophoblastic disease.
    Skinner MS; Seckinger D
    Ann Clin Lab Sci; 1979; 9(4):347-52. PubMed ID: 225983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
    O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
    Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
    Shimizu T; Matsuura S; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct; 35(10):1759-66. PubMed ID: 6195275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo release of beta human chorionic gonadotropin by luteinizing hormone releasing hormone stimulation and its clinical application as a remission criterion in patients with gestational trophoblastic disease.
    Kim SJ; Jung JK; Kang BC; Namkoong SE; Lee JW
    Int J Gynaecol Obstet; 1988 Oct; 27(2):193-8. PubMed ID: 2460385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gestational trophoblast tumors--rare, but important in general practice].
    Ebeling K; Schönborn I; Johannsmeyer D
    Z Arztl Fortbild (Jena); 1994 Oct; 88(10):773-8. PubMed ID: 7529957
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer].
    Nishimura R; Kobayashi K; Katsuno M; Kobayashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):143-8. PubMed ID: 1690253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.